ArticlePloS one2025
DeepRice6mA: A convolutional neural network approach for 6mA site prediction in the rice Genome.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetic Divergence and Functional Significance of Bioactive Compounds in Rice and Barley: Implications for Biofortification and Human Health.International journal of molecular sciences · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As one of the most critical post-replication modifications, N6-methylation (6mA) at adenine residue plays an important role in a variety of biological functions. Existing computational methods for identifying 6mA sites across large genomic regions tend to fall short in either accuracy or computational efficiency. To address this, we introduce DeepRice6mA, a sophisticated comprehensive predictive tool for identifying rice 6mA sites, using a deep learning approach that incorporates ensemble strategies from one-hot encoding and 3-kmer feature embedding. The proposed model, labeled DeepRice6mA, reaches state-of-the-art results compared to current approaches, with 10-fold cross-validation scores of 98% for accuracy, 98% for sensitivity, 98% for specificity, a Matthew's correlation coefficient (MCC) of 0.96, and an area under the receiver operating characteristic curve (AUC) of 0.99. We anticipate that DeepRice6mA will significantly enhance our understanding of DNA methylation and its implications for biological processes and disease states.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.